Skip to main content
TipRanks
Go Ultimate75% OFF

COSCIENS Biopharma (CSCIF) Revenue

904 Followers

COSCIENS Biopharma Revenue

COSCIENS Biopharma had a revenue of 3.06M in the quarter ending Jun 30, 2026, with 64.88%. This bring the company's revenue in the last twelve months to 8.18M, Increased 3.52%. In the fiscal year ending Dec 31, 2025, COSCIENS Biopharma had annual revenue of 7.63M with -20.42% growth.

Revenue (ttm)
8.18M
Revenue Growth
-12.31%
P/S Ratio
0.77
Revenue/Employee
$272,473
Employees
28
Market Cap
$5.87M

Revenue Chart

COSCIENS Biopharma Revenue - Annual

05M10M15M20M25M30M923.00K26.88M532.00K3.65M5.26M14.57M4.50M9.59M7.63M201720182019202020212022202320252025
Revenue History
Download to Excel
CSCIF revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20257.63M-1.96M-20.42%
Mar 31, 20259.59M5.09M113.14%
Dec 31, 20234.50M-10.07M-69.13%
Dec 31, 202214.57M9.31M177.03%
Dec 31, 20215.26M1.61M44.03%
Dec 31, 20203.65M3.12M586.47%
Dec 31, 2019532.00K-26.35M-98.02%
Dec 31, 201826.88M25.96M2812.35%
Dec 31, 2017923.00K――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
CSCIF8.18M
TSE:BETR0.00
TSE:PHRM0.00
TSE:GLOW2.31M
TSE:MRVL0.00
TSE:MDMA1.27M